Excretion of tritium after therapeutic injections of tritiated 2-methyl-1: 4-naphthaquinol diphosphate in cancer patients
- 15 July 1967
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 2 (4), 396-405
- https://doi.org/10.1002/ijc.2910020414
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Tritium uptake, half-lives and radiation doses in tissues of cancer patients treated with tritiated 2-methyl-1: 4-naphthaquinol diphosphateInternational Journal of Cancer, 1967
- An attempt to develop a radioactive drugClinical Radiology, 1965
- H3 Incorporation into Ascites Tumour and Tissue Culture Cells Exposed to Synkavit and its Tritiated AnalogueActa Radiologica, 1961
- Laboratory and Clinical Studies of Some Quinol Diphosphates and Related Compounds as Chemical Radiosensitizers and the Development of a Radioactive Drug (Part 1 of 4)Chemotherapy, 1961
- Clinical and Laboratory Studies of the Therapeutic Possibilities of Tritiated Synkavit, Mainly by Intra-Arterial AdministrationActa Radiologica, 1959
- Tracer Studies of Potential Radiosensitizing Agents. Tetrasodium 2-14C-Methyl-1:4-Naphthohydroquinone DiphosphateBritish Journal of Cancer, 1956
- URINARY EXCRETION PRODUCTS OF MENADIONE (VITAMIN K3)Canadian Journal of Biochemistry and Physiology, 1954
- Excretion of benzoyl glucuronate as a test of liver functionAmerican Journal Of Medicine, 1947
- Experimental Corroboration of the Mechanism of Biological Action of Quinones of the Type of Vitamin KNature, 1944